Literature DB >> 19850661

Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis.

Pasquale Esposito1, Mario M Balletta, Alfredo Procino, Loredana Postiglione, Bruno Memoli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19850661     DOI： 10.1177/0961203309106183

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  11 in total

1.  Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.

Authors:  Weijia Yuan; Stephen J DiMartino; Patricia B Redecha; Lionel B Ivashkiv; Jane E Salmon
Journal:  Arthritis Rheum       Date:  2011-01

2.  Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN.

Authors:  Michael Luig; Malte A Kluger; Boeren Goerke; Matthias Meyer; Anna Nosko; Isabell Yan; Jürgen Scheller; Hans-Willi Mittrücker; Stefan Rose-John; Rolf A K Stahl; Ulf Panzer; Oliver M Steinmetz
Journal:  J Am Soc Nephrol       Date:  2015-02-05       Impact factor: 10.121

Review 3.  B-cell-targeted therapies in systemic lupus erythematosus.

Authors:  Vera Sau-Fong Chan; Helen Hoi-Lun Tsang; Rachel Chun-Yee Tam; Liwei Lu; Chak-Sing Lau
Journal:  Cell Mol Immunol       Date:  2013-01-28       Impact factor: 11.530

Review 4.  Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances.

Authors:  Desmond Yat Hin Yap; Kar Neng Lai
Journal:  J Biomed Biotechnol       Date:  2010-05-06

5.  Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus.

Authors:  Lijun Song; Feng Qiu; Yuchen Fan; Feng Ding; Huaxiang Liu; Qiang Shu; Weiwei Liu; Xingfu Li
Journal:  J Clin Immunol       Date:  2012-09-09       Impact factor: 8.317

Review 6.  Cytokine disturbances in systemic lupus erythematosus.

Authors:  Noam Jacob; William Stohl
Journal:  Arthritis Res Ther       Date:  2011-07-06       Impact factor: 5.156

7.  Serum Cyr61 is associated with clinical disease activity and inflammation in patients with systemic lupus erythematosus.

Authors:  Jinpiao Lin; Ningli Li; Huijuan Chen; Can Liu; Bin Yang; Qishui Ou
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

8.  Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.

Authors:  Vinod Umare; Vandana Pradhan; Milind Nadkar; Anjali Rajadhyaksha; Manisha Patwardhan; Kanjaksha K Ghosh; Anita H Nadkarni
Journal:  Mediators Inflamm       Date:  2014-12-07       Impact factor: 4.711

9.  Delivering Oxidation Resistance-1 (OXR1) to Mouse Kidney by Genetic Modified Mesenchymal Stem Cells Exhibited Enhanced Protection against Nephrotoxic Serum Induced Renal Injury and Lupus Nephritis.

Authors:  Yajuan Li; Wei Li; Chu Liu; Mei Yan; Indu Raman; Yong Du; Xiangdong Fang; Xin J Zhou; Chandra Mohan; Quan-Zhen Li
Journal:  J Stem Cell Res Ther       Date:  2014-09-10

10.  Dysregulated cytokine production by dendritic cells modulates B cell responses in the NZM2410 mouse model of lupus.

Authors:  Allison Sang; Ying-Yi Zheng; Yiming Yin; Igor Dozmorov; Hao Li; Hui-Chen Hsu; John D Mountz; Laurence Morel
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.